Keyphrases
Risk Factors
100%
HLA-DRB1
100%
Scleroderma Renal Crisis
100%
Anti-RNA Polymerase III Antibodies
37%
Systemic Sclerosis
37%
Anti-centromere Antibody
37%
Independent Risk Factors
25%
Multivariate Analysis
25%
Scleroderma
25%
Disease Pattern
25%
Clinical Correlation
25%
Odds Ratio
25%
Confidence Interval
25%
DRB1
25%
Diffuse Disease
25%
Anti-topoisomerase I Antibodies
25%
University of Texas
12%
Autoantibodies
12%
Houston
12%
Clinical Data
12%
Genomic DNA (gDNA)
12%
Health Sciences Center
12%
Large Population
12%
Clinical Parameters
12%
Chart Review
12%
Clinical Characteristics
12%
Genetic Markers
12%
Predictive Role
12%
Rheumatology
12%
Disease Subtypes
12%
Diffuse Cutaneous
12%
Cutaneous Disease
12%
Final Model
12%
Commercially Available Kit
12%
HLA Class II
12%
HLA Alleles
12%
Family Registry
12%
Demographic Parameters
12%
Medicine and Dentistry
Scleroderma
100%
HLA-DRB1
100%
Systemic Scleroderma
30%
Centromere Antibody
30%
DNA Directed RNA Polymerase III
30%
Disease
20%
Multivariate Analysis
20%
Odds Ratio
20%
Division
10%
Genomic DNA
10%
Allele
10%
Dermatosis
10%
Autoantibodies
10%
Rheumatology
10%
Genetic Marker
10%
Pharmacology, Toxicology and Pharmaceutical Science
Scleroderma
100%
HLA DRB1 Antigen
100%
Centromere Antibody
30%
Systemic Sclerosis
30%
DNA Directed RNA Polymerase III
30%
Disease
20%
Autoantibodies
10%
Genomic DNA
10%
Skin Disease
10%
Immunology and Microbiology
Scleroderma
100%
HLA DRB1 Antigen
100%
RNA Polymerase
30%
Systemic Scleroderma
30%
Centromere Antibody
30%
Immunology
20%
Autoantibodies
10%
Allele
10%
Genetic Marker
10%